Genetron Holdings Limited (NASDAQ:GTH) shareholders will doubtless be very grateful to see the share price up 36% in the last week. But that doesn't change the fact that the returns over the last year ...

BEIJING, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in ...

The company's third-quarter report included some positive news. Investors' enthusiasm for Chinese companies in general has been lagging lately. Genetron reported its third-quarter earnings before the ...

Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharm, has a leading liver drug franchise with a major presence in liver disease hospitals in China Genetron Health anticipates ...

HCCscreenTM was selected by the National Cancer Center and the Wuxi municipal government for use in the “Liver Cancer Early Screening Comprehensive Prevention and Control Project”, a public health ...

BEIJING--(BUSINESS WIRE)--Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical ...

BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in ...

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer ...

BEIJING--(BUSINESS WIRE)--Genetron Holding Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, has announced a strategic partnership with Beijing ...

BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (GTH) (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in ...